Primary Hepatocytes Market Size, Share, and Growth Forecast 2026 - 2033

Primary Hepatocytes Market by Product (Cryopreserved Suspension Hepatocytes, Fresh Suspension Hepatocytes, 3D (Spheroid) Hepatocytes, Expanded Hepatocytes (Plateable), Non-characterized Hepatocytes), Species (Human, Rat, Mouse, Dog, Monkey, Others), Application (Drug Metabolism & Pharmacokinetics (DMPK), Toxicity Testing, Drug Discovery & Development, ADME Studies, Disease Modeling, Regenerative Medicine & Cell Therapy Research, Others), End-user, and Regional Analysis, 2026 - 2033

ID: PMRREP32880
Calendar

August 2026

187 Pages

Author : Pravin Rewale

  1. Executive Summary
    1. Global Primary Hepatocytes Market Snapshot 2026 and 2033
    2. Market Opportunity Assessment, 2026-2033, US$ Mn
    3. Key Market Trends
    4. Industry Developments and Key Market Events
    5. Demand Side and Supply Side Analysis
    6. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definitions
    2. Value Chain Analysis
    3. Macro-Economic Factors
      1. Global GDP Outlook
      2. Global Healthcare Expenditure
    4. Forecast Factors - Relevance and Impact
    5. PESTLE Analysis
    6. Porter's Five Forces Analysis
    7. Product Adoption Anlaysis
    8. Regulatory and Technology Landscape
  3. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. Global Primary Hepatocytes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Global Primary Hepatocytes Market Outlook: Product
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Mn) Analysis by Product, 2020-2025
      3. Current Market Size (US$ Mn) Forecast, by Product, 2026-2033
        1. Cryopreserved Suspension Hepatocytes
        2. Fresh Suspension Hepatocytes
        3. 3D (Spheroid) Hepatocytes
        4. Expanded Hepatocytes (Plateable)
        5. Non-characterized Hepatocytes
      4. Market Attractiveness Analysis: Product
    3. Global Primary Hepatocytes Market Outlook: Species
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Mn) Analysis by Species, 2020-2025
      3. Current Market Size (US$ Mn) Forecast, by Species, 2026-2033
        1. Human
        2. Rat
        3. Mouse
        4. Dog
        5. Monkey
        6. Others
      4. Market Attractiveness Analysis: Species
    4. Global Primary Hepatocytes Market Outlook: Application
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Mn) Analysis by Application, 2020-2025
      3. Current Market Size (US$ Mn) Forecast, by Application, 2026-2033
        1. Drug Metabolism & Pharmacokinetics (DMPK)
        2. Toxicity Testing
        3. Drug Discovery & Development
        4. ADME Studies
        5. Disease Modeling
        6. Regenerative Medicine & Cell Therapy Research
        7. Others
      4. Market Attractiveness Analysis: Application
    5. Global Primary Hepatocytes Market Outlook: End User
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Mn) Analysis by End User, 2020-2025
      3. Current Market Size (US$ Mn) Forecast, by End User, 2026-2033
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations (CROs)
        3. Academic & Research Institutes
        4. Hospitals & Diagnostic Laboratories
        5. Government & Regulatory Research Organizations
      4. Market Attractiveness Analysis: End User
  5. Global Primary Hepatocytes Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis by Region, 2020-2025
    3. Current Market Size (US$ Mn) Forecast, by Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Primary Hepatocytes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. North America Market Size (US$ Mn) Forecast, by Country, 2026-2033
      1. U.S.
      2. Canada
    3. North America Market Size (US$ Mn) Forecast, by Product, 2026-2033
      1. Cryopreserved Suspension Hepatocytes
      2. Fresh Suspension Hepatocytes
      3. 3D (Spheroid) Hepatocytes
      4. Expanded Hepatocytes (Plateable)
      5. Non-characterized Hepatocytes
    4. North America Market Size (US$ Mn) Forecast, by Species, 2026-2033
      1. Human
      2. Rat
      3. Mouse
      4. Dog
      5. Monkey
      6. Others
    5. North America Market Size (US$ Mn) Forecast, by Application, 2026-2033
      1. Drug Metabolism & Pharmacokinetics (DMPK)
      2. Toxicity Testing
      3. Drug Discovery & Development
      4. ADME Studies
      5. Disease Modeling
      6. Regenerative Medicine & Cell Therapy Research
      7. Others
    6. North America Market Size (US$ Mn) Forecast, by End User, 2026-2033
      1. Pharmaceutical & Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic & Research Institutes
      4. Hospitals & Diagnostic Laboratories
      5. Government & Regulatory Research Organizations
  7. Europe Primary Hepatocytes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Europe Market Size (US$ Mn) Forecast, by Country, 2026-2033
      1. Germany
      2. Italy
      3. France
      4. U.K.
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Europe Market Size (US$ Mn) Forecast, by Product, 2026-2033
      1. Cryopreserved Suspension Hepatocytes
      2. Fresh Suspension Hepatocytes
      3. 3D (Spheroid) Hepatocytes
      4. Expanded Hepatocytes (Plateable)
      5. Non-characterized Hepatocytes
    4. Europe Market Size (US$ Mn) Forecast, by Species, 2026-2033
      1. Human
      2. Rat
      3. Mouse
      4. Dog
      5. Monkey
      6. Others
    5. Europe Market Size (US$ Mn) Forecast, by Application, 2026-2033
      1. Drug Metabolism & Pharmacokinetics (DMPK)
      2. Toxicity Testing
      3. Drug Discovery & Development
      4. ADME Studies
      5. Disease Modeling
      6. Regenerative Medicine & Cell Therapy Research
      7. Others
    6. Europe Market Size (US$ Mn) Forecast, by End User, 2026-2033
      1. Pharmaceutical & Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic & Research Institutes
      4. Hospitals & Diagnostic Laboratories
      5. Government & Regulatory Research Organizations
  8. East Asia Primary Hepatocytes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. East Asia Market Size (US$ Mn) Forecast, by Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    3. East Asia Market Size (US$ Mn) Forecast, by Product, 2026-2033
      1. Cryopreserved Suspension Hepatocytes
      2. Fresh Suspension Hepatocytes
      3. 3D (Spheroid) Hepatocytes
      4. Expanded Hepatocytes (Plateable)
      5. Non-characterized Hepatocytes
    4. East Asia Market Size (US$ Mn) Forecast, by Species, 2026-2033
      1. Human
      2. Rat
      3. Mouse
      4. Dog
      5. Monkey
      6. Others
    5. East Asia Market Size (US$ Mn) Forecast, by Application, 2026-2033
      1. Drug Metabolism & Pharmacokinetics (DMPK)
      2. Toxicity Testing
      3. Drug Discovery & Development
      4. ADME Studies
      5. Disease Modeling
      6. Regenerative Medicine & Cell Therapy Research
      7. Others
    6. East Asia Market Size (US$ Mn) Forecast, by End User, 2026-2033
      1. Pharmaceutical & Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic & Research Institutes
      4. Hospitals & Diagnostic Laboratories
      5. Government & Regulatory Research Organizations
  9. South Asia & Oceania Primary Hepatocytes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of SAO
    3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Product, 2026-2033
      1. Cryopreserved Suspension Hepatocytes
      2. Fresh Suspension Hepatocytes
      3. 3D (Spheroid) Hepatocytes
      4. Expanded Hepatocytes (Plateable)
      5. Non-characterized Hepatocytes
    4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Species, 2026-2033
      1. Human
      2. Rat
      3. Mouse
      4. Dog
      5. Monkey
      6. Others
    5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Application, 2026-2033
      1. Drug Metabolism & Pharmacokinetics (DMPK)
      2. Toxicity Testing
      3. Drug Discovery & Development
      4. ADME Studies
      5. Disease Modeling
      6. Regenerative Medicine & Cell Therapy Research
      7. Others
    6. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2026-2033
      1. Pharmaceutical & Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic & Research Institutes
      4. Hospitals & Diagnostic Laboratories
      5. Government & Regulatory Research Organizations
  10. Latin America Primary Hepatocytes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Latin America Market Size (US$ Mn) Forecast, by Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of LATAM
    3. Latin America Market Size (US$ Mn) Forecast, by Product, 2026-2033
      1. Cryopreserved Suspension Hepatocytes
      2. Fresh Suspension Hepatocytes
      3. 3D (Spheroid) Hepatocytes
      4. Expanded Hepatocytes (Plateable)
      5. Non-characterized Hepatocytes
    4. Latin America Market Size (US$ Mn) Forecast, by Species, 2026-2033
      1. Human
      2. Rat
      3. Mouse
      4. Dog
      5. Monkey
      6. Others
    5. Latin America Market Size (US$ Mn) Forecast, by Application, 2026-2033
      1. Drug Metabolism & Pharmacokinetics (DMPK)
      2. Toxicity Testing
      3. Drug Discovery & Development
      4. ADME Studies
      5. Disease Modeling
      6. Regenerative Medicine & Cell Therapy Research
      7. Others
    6. Latin America Market Size (US$ Mn) Forecast, by End User, 2026-2033
      1. Pharmaceutical & Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic & Research Institutes
      4. Hospitals & Diagnostic Laboratories
      5. Government & Regulatory Research Organizations
  11. Middle East & Africa Primary Hepatocytes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2026-2033
      1. GCC Countries
      2. South Africa
      3. Northern Africa
      4. Rest of MEA
    3. Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2026-2033
      1. Cryopreserved Suspension Hepatocytes
      2. Fresh Suspension Hepatocytes
      3. 3D (Spheroid) Hepatocytes
      4. Expanded Hepatocytes (Plateable)
      5. Non-characterized Hepatocytes
    4. Middle East & Africa Market Size (US$ Mn) Forecast, by Species, 2026-2033
      1. Human
      2. Rat
      3. Mouse
      4. Dog
      5. Monkey
      6. Others
    5. Middle East & Africa Market Size (US$ Mn) Forecast, by Application, 2026-2033
      1. Drug Metabolism & Pharmacokinetics (DMPK)
      2. Toxicity Testing
      3. Drug Discovery & Development
      4. ADME Studies
      5. Disease Modeling
      6. Regenerative Medicine & Cell Therapy Research
      7. Others
    6. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2026-2033
      1. Pharmaceutical & Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic & Research Institutes
      4. Hospitals & Diagnostic Laboratories
      5. Government & Regulatory Research Organizations
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping
      2. Competition Dashboard
    3. Company Profiles
      1. Lonza Group AG
        1. Company Overview
        2. Product Portfolio/Offerings
        3. Key Financials
        4. SWOT Analysis
        5. Company Strategy and Key Developments
      2. Thermo Fisher Scientific Inc.
      3. BioIVT LLC
      4. Sekisui XenoTech, LLC
      5. Corning Incorporated
      6. Cell Biologics, Inc.
      7. ScienCell Research Laboratories, Inc.
      8. Creative Bioarray
      9. ZenBio, Inc.
      10. PromoCell GmbH
      11. Axol Bioscience Ltd.
      12. BioPredic International
      13. InSphero AG
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -